speb/financial-data huggingface dataset:
BMI cash_flow (quarterly, 2025-03-31) — Capital Expenditure Reported: -2966000.00
BMI balance_sheet (quarterly, 2025-03-31) — Capital Stock: 37221000.00
BMI balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 131358000.00
BMI balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 131358000.00
BMI cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -10017000.00
BMI cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -9949000.00
BMI cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -187903000.00
BMI cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 33027000.00
BMI cash_flow (quarterly, 2025-03-31) — Change In Inventory: -120000.00
BMI cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -7088000.00
BMI cash_flow (quarterly, 2025-03-31) — Change In Payable: 16294000.00
BMI cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 16294000.00
BMI cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -4107000.00
BMI cash_flow (quarterly, 2025-03-31) — Change In Receivables: -20497000.00
BMI cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -15518000.00
BMI cash_flow (quarterly, 2025-03-31) — Changes In Cash: -164825000.00
BMI balance_sheet (quarterly, 2025-03-31) — Common Stock: 37221000.00
BMI cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: -10017000.00
BMI balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 641686000.00
BMI cash_flow (quarterly, 2025-03-31) — Common Stock Payments: 0.00
BMI income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 126774000.00
BMI balance_sheet (quarterly, 2025-03-31) — Current Assets: 411577000.00
BMI balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 141017000.00
BMI balance_sheet (quarterly, 2025-03-31) — Current Provisions: 6638000.00
BMI cash_flow (quarterly, 2025-03-31) — Depreciation: 2804000.00
BMI cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 8282000.00
BMI cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 8282000.00
BMI income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 29564797.00
BMI income_statement (quarterly, 2025-03-31) — Diluted EPS: 1.30
BMI income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 38398000.00
BMI income_statement (quarterly, 2025-03-31) — EBIT: 49425000.00
BMI income_statement (quarterly, 2025-03-31) — EBITDA: 57707000.00
BMI cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 878000.00
BMI balance_sheet (quarterly, 2025-03-31) — Employee Benefits: 9515000.00
BMI cash_flow (quarterly, 2025-03-31) — End Cash Position: 131358000.00
BMI cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -9949000.00
BMI balance_sheet (quarterly, 2025-03-31) — Finished Goods: 23145000.00
BMI cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 30061000.00
BMI balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -2748000.00
BMI balance_sheet (quarterly, 2025-03-31) — Goodwill: 231538000.00
BMI balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 362629000.00
BMI balance_sheet (quarterly, 2025-03-31) — Gross PPE: 238032000.00
BMI income_statement (quarterly, 2025-03-31) — Gross Profit: 95437000.00
BMI income_statement (quarterly, 2025-03-31) — Interest Income: 1334000.00
BMI income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 1334000.00
BMI balance_sheet (quarterly, 2025-03-31) — Inventory: 149405000.00
BMI balance_sheet (quarterly, 2025-03-31) — Invested Capital: 641686000.00
BMI cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -187903000.00
BMI cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: -184937000.00
BMI cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 0.00
BMI income_statement (quarterly, 2025-03-31) — Net Income: 38398000.00
BMI income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 38398000.00
BMI income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 38398000.00
BMI income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 38398000.00
BMI income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 38398000.00
BMI cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 38398000.00
BMI income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 38398000.00
BMI income_statement (quarterly, 2025-03-31) — Net Interest Income: 1334000.00
BMI income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 1334000.00
BMI balance_sheet (quarterly, 2025-03-31) — Net PPE: 75687000.00
BMI balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 279057000.00
BMI balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 32580000.00
BMI balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 89732000.00
BMI balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 65445000.00
BMI balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 32580000.00
BMI balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 24287000.00
BMI balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 3289000.00
BMI income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 57707000.00
BMI income_statement (quarterly, 2025-03-31) — Normalized Income: 38398000.00
BMI cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 33027000.00
BMI cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 37000.00
BMI income_statement (quarterly, 2025-03-31) — Operating Income: 49425000.00
BMI income_statement (quarterly, 2025-03-31) — Operating Revenue: 222211000.00
BMI balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 29453307.00
BMI balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 18959000.00
BMI balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 43292000.00
BMI balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -2748000.00
BMI income_statement (quarterly, 2025-03-31) — Other Income Expense: 28000.00
BMI balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 131091000.00
BMI balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 17123000.00
BMI balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 17646000.00
BMI income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 28000.00
BMI balance_sheet (quarterly, 2025-03-31) — Payables: 73789000.00
BMI balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 73789000.00
BMI cash_flow (quarterly, 2025-03-31) — Pension And Employee Benefit Expense: 37000.00
BMI balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 17298000.00
BMI income_statement (quarterly, 2025-03-31) — Pretax Income: 50787000.00
BMI cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 68000.00
BMI cash_flow (quarterly, 2025-03-31) — Purchase Of Business: -184937000.00
BMI balance_sheet (quarterly, 2025-03-31) — Raw Materials: 87973000.00
BMI balance_sheet (quarterly, 2025-03-31) — Receivables: 111855000.00
BMI income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 126774000.00
BMI income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 8282000.00
BMI cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: 0.00
BMI balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 576196000.00
BMI income_statement (quarterly, 2025-03-31) — Selling General And Administration: 46012000.00
BMI balance_sheet (quarterly, 2025-03-31) — Share Issued: 37221098.00
BMI cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 1828000.00
BMI balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 641686000.00
BMI balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 279057000.00
BMI income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
BMI income_statement (quarterly, 2025-03-31) — Tax Provision: 12389000.00
BMI income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.24
BMI balance_sheet (quarterly, 2025-03-31) — Total Assets: 899596000.00
BMI balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 641686000.00
BMI balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 641686000.00
BMI income_statement (quarterly, 2025-03-31) — Total Expenses: 172786000.00
BMI balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 257910000.00
BMI balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 488019000.00
BMI balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 116893000.00
BMI income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 49425000.00
BMI balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 7767791.00
BMI balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 36499000.00
BMI balance_sheet (quarterly, 2025-03-31) — Work In Process: 38287000.00
BMI balance_sheet (quarterly, 2025-03-31) — Working Capital: 270560000.00
BMI income_statement (quarterly, 2025-06-30) — +Operating Expense: 52947000.00
BMI income_statement (quarterly, 2025-06-30) — +Total Revenue: 238095000.00
BMI balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 74125000.00
BMI balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 117667000.00
BMI balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -166811000.00
BMI balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 70505000.00
BMI cash_flow (quarterly, 2025-06-30) — Amortization Cash Flow: 5880000.00
BMI cash_flow (quarterly, 2025-06-30) — Amortization Of Intangibles: 5880000.00
BMI income_statement (quarterly, 2025-06-30) — Basic Average Shares: 29414457.00
BMI income_statement (quarterly, 2025-06-30) — Basic EPS: 1.18
BMI cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 131358000.00
BMI cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -3938000.00
BMI cash_flow (quarterly, 2025-06-30) — Capital Expenditure Reported: -3938000.00
BMI balance_sheet (quarterly, 2025-06-30) — Capital Stock: 37221000.00
BMI balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 165208000.00
BMI balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 165208000.00
BMI cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -10004000.00
BMI cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -9518000.00
BMI cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -3025000.00
BMI cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 44586000.00
BMI cash_flow (quarterly, 2025-06-30) — Change In Inventory: 4139000.00
BMI cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -1614000.00
BMI cash_flow (quarterly, 2025-06-30) — Change In Payable: -72000.00
BMI cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -72000.00
BMI cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 1019000.00
BMI cash_flow (quarterly, 2025-06-30) — Change In Receivables: -4809000.00
BMI cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -1337000.00
BMI cash_flow (quarterly, 2025-06-30) — Changes In Cash: 32043000.00
BMI balance_sheet (quarterly, 2025-06-30) — Common Stock: 37221000.00
BMI cash_flow (quarterly, 2025-06-30) — Common Stock Dividend Paid: -10004000.00
BMI balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 677592000.00
BMI cash_flow (quarterly, 2025-06-30) — Common Stock Payments: 0.00
BMI income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 140285000.00
BMI balance_sheet (quarterly, 2025-06-30) — Current Assets: 448275000.00
BMI balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 138710000.00
BMI balance_sheet (quarterly, 2025-06-30) — Current Provisions: 9828000.00
BMI cash_flow (quarterly, 2025-06-30) — Depreciation: 2915000.00
BMI cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 8795000.00
BMI cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 8795000.00
BMI income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 29585340.00
BMI income_statement (quarterly, 2025-06-30) — Diluted EPS: 1.17
BMI income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 34584000.00
BMI income_statement (quarterly, 2025-06-30) — EBIT: 44863000.00
BMI income_statement (quarterly, 2025-06-30) — EBITDA: 53658000.00
BMI cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 1807000.00
BMI balance_sheet (quarterly, 2025-06-30) — Employee Benefits: 10903000.00
BMI cash_flow (quarterly, 2025-06-30) — End Cash Position: 165208000.00
BMI cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -9518000.00
BMI balance_sheet (quarterly, 2025-06-30) — Finished Goods: 24499000.00
BMI cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 40648000.00
BMI balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 5529000.00
BMI balance_sheet (quarterly, 2025-06-30) — Goodwill: 235699000.00
BMI balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 361808000.00
BMI balance_sheet (quarterly, 2025-06-30) — Gross PPE: 244748000.00
BMI income_statement (quarterly, 2025-06-30) — Gross Profit: 97810000.00
BMI income_statement (quarterly, 2025-06-30) — Interest Income: 895000.00
BMI income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 895000.00
BMI balance_sheet (quarterly, 2025-06-30) — Inventory: 147261000.00
BMI balance_sheet (quarterly, 2025-06-30) — Invested Capital: 677592000.00
BMI cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -3025000.00
BMI cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: 913000.00
BMI cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 0.00
BMI income_statement (quarterly, 2025-06-30) — Net Income: 34584000.00
BMI income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 34584000.00
BMI income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 34584000.00
BMI income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 34584000.00
BMI income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 34584000.00
BMI cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 34584000.00
BMI income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 34584000.00
BMI income_statement (quarterly, 2025-06-30) — Net Interest Income: 895000.00
BMI income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 895000.00
BMI balance_sheet (quarterly, 2025-06-30) — Net PPE: 77937000.00
BMI balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 315784000.00
BMI balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 32692000.00
BMI balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 92654000.00
BMI balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Revenue: 68545000.00
BMI balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 32692000.00
BMI balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 24109000.00
BMI balance_sheet (quarterly, 2025-06-30) — Non Current Pension And Other Postretirement Benefit Plans: 3340000.00
BMI income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 53658000.00
BMI income_statement (quarterly, 2025-06-30) — Normalized Income: 34584000.00
BMI cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 44586000.00
BMI cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -32000.00
BMI income_statement (quarterly, 2025-06-30) — Operating Income: 44863000.00
BMI income_statement (quarterly, 2025-06-30) — Operating Revenue: 238095000.00
BMI balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 29468808.00
BMI balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 18139000.00
BMI balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 30932000.00
BMI balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 5529000.00
BMI income_statement (quarterly, 2025-06-30) — Other Income Expense: 28000.00
BMI balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 126109000.00
BMI balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 15708000.00
BMI balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 16561000.00
BMI income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 28000.00
BMI balance_sheet (quarterly, 2025-06-30) — Payables: 74125000.00
BMI balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 74125000.00
BMI cash_flow (quarterly, 2025-06-30) — Pension And Employee Benefit Expense: -32000.00
BMI balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 23825000.00
BMI income_statement (quarterly, 2025-06-30) — Pretax Income: 45786000.00
BMI cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 486000.00
BMI cash_flow (quarterly, 2025-06-30) — Purchase Of Business: 913000.00
BMI balance_sheet (quarterly, 2025-06-30) — Raw Materials: 89233000.00
BMI balance_sheet (quarterly, 2025-06-30) — Receivables: 117667000.00
BMI income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 140285000.00
BMI income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 8795000.00
BMI cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: 0.00
BMI balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 600763000.00
BMI income_statement (quarterly, 2025-06-30) — Selling General And Administration: 52947000.00
BMI balance_sheet (quarterly, 2025-06-30) — Share Issued: 37221098.00
BMI cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 2576000.00
BMI balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 677592000.00
BMI balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 315784000.00
BMI income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
BMI income_statement (quarterly, 2025-06-30) — Tax Provision: 11202000.00
BMI income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.24
BMI balance_sheet (quarterly, 2025-06-30) — Total Assets: 936420000.00
BMI balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 677592000.00
BMI balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 677592000.00
BMI income_statement (quarterly, 2025-06-30) — Total Expenses: 193232000.00
BMI balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 258828000.00
BMI balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 488145000.00
BMI balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 120118000.00
BMI income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 44863000.00
BMI balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 7752290.00
BMI balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 36426000.00
BMI balance_sheet (quarterly, 2025-06-30) — Work In Process: 33529000.00
BMI balance_sheet (quarterly, 2025-06-30) — Working Capital: 309565000.00
BMI income_statement (quarterly, 2025-09-30) — +Operating Expense: 49752000.00
BMI income_statement (quarterly, 2025-09-30) — +Total Revenue: 235651000.00
BMI balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 69786000.00
BMI balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 115056000.00
BMI balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -167855000.00
BMI balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 72541000.00
BMI cash_flow (quarterly, 2025-09-30) — Amortization Cash Flow: 6100000.00
BMI cash_flow (quarterly, 2025-09-30) — Amortization Of Intangibles: 6100000.00
BMI income_statement (quarterly, 2025-09-30) — Basic Average Shares: 29424004.00
BMI income_statement (quarterly, 2025-09-30) — Basic EPS: 1.19
BMI cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 165208000.00
BMI cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -3089000.00
BMI balance_sheet (quarterly, 2025-09-30) — Capital Stock: 37221000.00
BMI balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 201693000.00
BMI balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 201693000.00
BMI cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -11770000.00
BMI cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -11770000.00
BMI cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -3089000.00
BMI cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 51284000.00
BMI cash_flow (quarterly, 2025-09-30) — Change In Inventory: -5759000.00
BMI cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: 13148000.00
BMI cash_flow (quarterly, 2025-09-30) — Change In Payable: -4285000.00
BMI cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -4285000.00
BMI cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -188000.00
BMI cash_flow (quarterly, 2025-09-30) — Change In Receivables: 2503000.00
BMI cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 5419000.00
BMI cash_flow (quarterly, 2025-09-30) — Changes In Cash: 36425000.00
BMI balance_sheet (quarterly, 2025-09-30) — Common Stock: 37221000.00
BMI cash_flow (quarterly, 2025-09-30) — Common Stock Dividend Paid: -11770000.00
BMI balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 702510000.00
BMI income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 139815000.00
BMI balance_sheet (quarterly, 2025-09-30) — Current Assets: 494586000.00
BMI balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 153422000.00
BMI balance_sheet (quarterly, 2025-09-30) — Current Provisions: 8926000.00
BMI cash_flow (quarterly, 2025-09-30) — Depreciation: 2607000.00
BMI cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 8707000.00
BMI cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 8707000.00
BMI income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 29583384.00
BMI income_statement (quarterly, 2025-09-30) — Diluted EPS: 1.19
BMI income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 35077000.00
BMI income_statement (quarterly, 2025-09-30) — EBIT: 46084000.00
BMI income_statement (quarterly, 2025-09-30) — EBITDA: 54791000.00
BMI cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: 60000.00
BMI balance_sheet (quarterly, 2025-09-30) — Employee Benefits: 9842000.00
BMI cash_flow (quarterly, 2025-09-30) — End Cash Position: 201693000.00
BMI cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -11770000.00
BMI balance_sheet (quarterly, 2025-09-30) — Finished Goods: 26180000.00
BMI cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 48195000.00
BMI balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 5115000.00
BMI balance_sheet (quarterly, 2025-09-30) — Goodwill: 236654000.00
BMI balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 358714000.00
BMI balance_sheet (quarterly, 2025-09-30) — Gross PPE: 246217000.00
BMI income_statement (quarterly, 2025-09-30) — Gross Profit: 95836000.00
BMI income_statement (quarterly, 2025-09-30) — Interest Income: 1330000.00
BMI income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 1330000.00
BMI balance_sheet (quarterly, 2025-09-30) — Inventory: 152627000.00
BMI balance_sheet (quarterly, 2025-09-30) — Invested Capital: 702510000.00
BMI cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -3089000.00
BMI cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: 0.00
BMI income_statement (quarterly, 2025-09-30) — Net Income: 35077000.00
BMI income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 35077000.00
BMI income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 35077000.00
BMI income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 35077000.00
BMI income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 35077000.00
BMI cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 35077000.00
BMI income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 35077000.00
BMI income_statement (quarterly, 2025-09-30) — Net Interest Income: 1330000.00
BMI income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 1330000.00
BMI balance_sheet (quarterly, 2025-09-30) — Net PPE: 78362000.00
BMI balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 343796000.00
BMI balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 32653000.00
BMI balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 93245000.00
BMI balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Revenue: 69180000.00
BMI balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 32653000.00
BMI balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 24065000.00
BMI balance_sheet (quarterly, 2025-09-30) — Non Current Pension And Other Postretirement Benefit Plans: 3395000.00
BMI income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 54791000.00
BMI income_statement (quarterly, 2025-09-30) — Normalized Income: 35077000.00
BMI cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 51284000.00
BMI cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 40000.00
BMI income_statement (quarterly, 2025-09-30) — Operating Income: 46084000.00
BMI income_statement (quarterly, 2025-09-30) — Operating Revenue: 235651000.00
BMI balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 29469785.00
BMI balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 25210000.00
BMI balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 41186000.00
BMI balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 5115000.00
BMI income_statement (quarterly, 2025-09-30) — Other Income Expense: 28000.00
BMI balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 122060000.00
BMI balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 13955000.00
BMI balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 19251000.00
BMI income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 28000.00
BMI balance_sheet (quarterly, 2025-09-30) — Payables: 69786000.00
BMI balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 69786000.00
BMI cash_flow (quarterly, 2025-09-30) — Pension And Employee Benefit Expense: 40000.00
BMI balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 33524000.00
BMI income_statement (quarterly, 2025-09-30) — Pretax Income: 47442000.00
BMI cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 0.00
BMI cash_flow (quarterly, 2025-09-30) — Purchase Of Business: 0.00
BMI balance_sheet (quarterly, 2025-09-30) — Raw Materials: 96156000.00
BMI balance_sheet (quarterly, 2025-09-30) — Receivables: 115056000.00
BMI income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 139815000.00
BMI income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 8707000.00
BMI balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 624054000.00
BMI income_statement (quarterly, 2025-09-30) — Selling General And Administration: 49752000.00
BMI balance_sheet (quarterly, 2025-09-30) — Share Issued: 37221098.00
BMI cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 2041000.00
BMI balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 702510000.00
BMI balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 343796000.00
BMI income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
BMI income_statement (quarterly, 2025-09-30) — Tax Provision: 12365000.00
BMI income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.26
BMI balance_sheet (quarterly, 2025-09-30) — Total Assets: 978270000.00
BMI balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 702510000.00
BMI balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 702510000.00
BMI income_statement (quarterly, 2025-09-30) — Total Expenses: 189567000.00
BMI balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 275760000.00
BMI balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 483684000.00
BMI balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 122338000.00
BMI income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 46084000.00
BMI balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 7751313.00
BMI balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 36421000.00
BMI balance_sheet (quarterly, 2025-09-30) — Work In Process: 30291000.00
BMI balance_sheet (quarterly, 2025-09-30) — Working Capital: 341164000.00
BMI income_statement (annual, 2025-12-31) — +Operating Expense: 198649000.00
BMI income_statement (quarterly, 2025-12-31) — +Operating Expense: 49938000.00
BMI income_statement (annual, 2025-12-31) — +Total Revenue: 916663000.00
BMI income_statement (quarterly, 2025-12-31) — +Total Revenue: 220706000.00
BMI balance_sheet (annual, 2025-12-31) — Accounts Payable: 72299000.00
BMI balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 72299000.00
BMI balance_sheet (annual, 2025-12-31) — Accounts Receivable: 112356000.00
BMI balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 112356000.00
BMI balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -168814000.00
BMI balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -168814000.00
BMI balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 75290000.00
BMI balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 75290000.00
BMI balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -2487000.00
BMI balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -2487000.00
BMI cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 23481000.00
BMI cash_flow (quarterly, 2025-12-31) — Amortization Cash Flow: 6023000.00
BMI cash_flow (annual, 2025-12-31) — Amortization Of Intangibles: 23481000.00
BMI cash_flow (quarterly, 2025-12-31) — Amortization Of Intangibles: 6023000.00
BMI income_statement (annual, 2025-12-31) — Basic Average Shares: 29398469.00
BMI income_statement (quarterly, 2025-12-31) — Basic Average Shares: 29375279.00
BMI income_statement (annual, 2025-12-31) — Basic EPS: 4.82
BMI income_statement (quarterly, 2025-12-31) — Basic EPS: 1.14
BMI cash_flow (annual, 2025-12-31) — Beginning Cash Position: 295305000.00
BMI cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 201693000.00
BMI balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 74956000.00
BMI balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 74956000.00
BMI cash_flow (annual, 2025-12-31) — Capital Expenditure: -14026000.00
BMI cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -4033000.00
BMI cash_flow (annual, 2025-12-31) — Capital Expenditure Reported: -14026000.00
BMI balance_sheet (annual, 2025-12-31) — Capital Stock: 37221000.00
BMI balance_sheet (quarterly, 2025-12-31) — Capital Stock: 37221000.00
BMI balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 226016000.00
BMI balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 226016000.00
BMI balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 226016000.00
BMI balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 226016000.00
BMI cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -43529000.00
BMI cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -11738000.00
BMI cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -57977000.00
BMI cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -26740000.00
BMI cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -198050000.00
BMI cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -4033000.00
BMI cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 183698000.00
BMI cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 54801000.00
BMI cash_flow (annual, 2025-12-31) — Change In Inventory: -987000.00
BMI cash_flow (quarterly, 2025-12-31) — Change In Inventory: 753000.00
BMI cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: 9515000.00
BMI cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: 5069000.00
BMI cash_flow (annual, 2025-12-31) — Change In Payable: 14399000.00
BMI cash_flow (quarterly, 2025-12-31) — Change In Payable: 2462000.00
BMI cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 14399000.00
BMI cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 2462000.00
BMI cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -3804000.00
BMI cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -528000.00
BMI cash_flow (annual, 2025-12-31) — Change In Receivables: -20115000.00
BMI cash_flow (quarterly, 2025-12-31) — Change In Receivables: 2688000.00
BMI cash_flow (annual, 2025-12-31) — Change In Working Capital: -992000.00
BMI cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 10444000.00
BMI cash_flow (annual, 2025-12-31) — Changes In Cash: -72329000.00
BMI cash_flow (quarterly, 2025-12-31) — Changes In Cash: 24028000.00
BMI balance_sheet (annual, 2025-12-31) — Common Stock: 37221000.00
BMI balance_sheet (quarterly, 2025-12-31) — Common Stock: 37221000.00
BMI cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -43529000.00
BMI cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: -11738000.00
BMI balance_sheet (annual, 2025-12-31) — Common Stock Equity: 713294000.00
BMI balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 713294000.00
BMI cash_flow (annual, 2025-12-31) — Common Stock Payments: -15002000.00
BMI income_statement (annual, 2025-12-31) — Cost Of Revenue: 534593000.00
BMI income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 127719000.00
BMI balance_sheet (annual, 2025-12-31) — Current Assets: 507077000.00
BMI balance_sheet (quarterly, 2025-12-31) — Current Assets: 507077000.00
BMI balance_sheet (annual, 2025-12-31) — Current Liabilities: 150716000.00
BMI balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 150716000.00
BMI balance_sheet (annual, 2025-12-31) — Current Provisions: 8466000.00
BMI balance_sheet (quarterly, 2025-12-31) — Current Provisions: 8466000.00
BMI cash_flow (annual, 2025-12-31) — Deferred Income Tax: -854000.00
BMI cash_flow (annual, 2025-12-31) — Deferred Tax: -854000.00
BMI cash_flow (annual, 2025-12-31) — Depreciation: 11103000.00
BMI cash_flow (quarterly, 2025-12-31) — Depreciation: 2777000.00
BMI cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 34584000.00
BMI cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 8800000.00
BMI cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 34584000.00
BMI cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 8800000.00
BMI income_statement (annual, 2025-12-31) — Diluted Average Shares: 29569496.00
BMI income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 29542816.00
BMI income_statement (annual, 2025-12-31) — Diluted EPS: 4.79
BMI income_statement (quarterly, 2025-12-31) — Diluted EPS: 1.14
BMI income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 141634000.00
BMI income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 33575000.00
BMI income_statement (annual, 2025-12-31) — EBIT: 183421000.00
BMI income_statement (quarterly, 2025-12-31) — EBIT: 43049000.00
BMI income_statement (annual, 2025-12-31) — EBITDA: 218005000.00
BMI income_statement (quarterly, 2025-12-31) — EBITDA: 51849000.00
BMI cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 3040000.00
BMI cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 295000.00
BMI balance_sheet (annual, 2025-12-31) — Employee Benefits: 9157000.00
BMI balance_sheet (quarterly, 2025-12-31) — Employee Benefits: 9157000.00
BMI cash_flow (annual, 2025-12-31) — End Cash Position: 226016000.00
BMI cash_flow (quarterly, 2025-12-31) — End Cash Position: 226016000.00
BMI cash_flow (annual, 2025-12-31) — Financing Cash Flow: -57977000.00
BMI cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -26740000.00
BMI balance_sheet (annual, 2025-12-31) — Finished Goods: 23087000.00
BMI balance_sheet (quarterly, 2025-12-31) — Finished Goods: 23087000.00
BMI cash_flow (annual, 2025-12-31) — Free Cash Flow: 169672000.00
BMI cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 50768000.00
BMI balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 6474000.00
BMI balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 6474000.00
BMI balance_sheet (annual, 2025-12-31) — Goodwill: 235575000.00
BMI balance_sheet (quarterly, 2025-12-31) — Goodwill: 235575000.00
BMI balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 357771000.00
BMI balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 357771000.00
BMI balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 114843000.00
BMI balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 114843000.00
BMI balance_sheet (annual, 2025-12-31) — Gross PPE: 248450000.00
BMI balance_sheet (quarterly, 2025-12-31) — Gross PPE: 248450000.00
BMI income_statement (annual, 2025-12-31) — Gross Profit: 382070000.00
BMI income_statement (quarterly, 2025-12-31) — Gross Profit: 92987000.00
BMI cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 48753000.00
BMI income_statement (annual, 2025-12-31) — Interest Income: 5124000.00
BMI income_statement (quarterly, 2025-12-31) — Interest Income: 1565000.00
BMI income_statement (annual, 2025-12-31) — Interest Income Non Operating: 5124000.00
BMI income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 1565000.00
BMI cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 0.00
BMI balance_sheet (annual, 2025-12-31) — Inventory: 151935000.00
BMI balance_sheet (quarterly, 2025-12-31) — Inventory: 151935000.00
BMI balance_sheet (annual, 2025-12-31) — Invested Capital: 713294000.00
BMI balance_sheet (quarterly, 2025-12-31) — Invested Capital: 713294000.00
BMI cash_flow (annual, 2025-12-31) — Investing Cash Flow: -198050000.00
BMI cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -4033000.00
BMI balance_sheet (annual, 2025-12-31) — Land And Improvements: 9544000.00
BMI balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 9544000.00
BMI balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 163950000.00
BMI balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 163950000.00
BMI cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: -184024000.00
BMI cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: 0.00
BMI cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -15002000.00
BMI income_statement (annual, 2025-12-31) — Net Income: 141634000.00
BMI income_statement (quarterly, 2025-12-31) — Net Income: 33575000.00
BMI income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 141634000.00
BMI income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 33575000.00
BMI income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 141634000.00
BMI income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 33575000.00
BMI income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 141634000.00
BMI income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 33575000.00
BMI income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 141634000.00
BMI income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 33575000.00
BMI cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 141634000.00
BMI cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 33575000.00
BMI income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 141634000.00
BMI income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 33575000.00
BMI income_statement (annual, 2025-12-31) — Net Interest Income: 5124000.00
BMI income_statement (quarterly, 2025-12-31) — Net Interest Income: 1565000.00
BMI income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 5124000.00
BMI income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 1565000.00
BMI balance_sheet (annual, 2025-12-31) — Net PPE: 79636000.00
BMI balance_sheet (quarterly, 2025-12-31) — Net PPE: 79636000.00
BMI balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 355523000.00
BMI balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 355523000.00
BMI balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 14140000.00
BMI balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 14140000.00
BMI balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 76248000.00
BMI balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 76248000.00
BMI balance_sheet (annual, 2025-12-31) — Non Current Deferred Revenue: 72771000.00
BMI balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Revenue: 72771000.00
BMI balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 14140000.00
BMI balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 14140000.00
BMI balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 3477000.00
BMI balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 3477000.00
BMI balance_sheet (annual, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 2499000.00
BMI balance_sheet (quarterly, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 2499000.00
BMI income_statement (annual, 2025-12-31) — Normalized EBITDA: 218005000.00
BMI income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 51849000.00
BMI income_statement (annual, 2025-12-31) — Normalized Income: 141634000.00
BMI income_statement (quarterly, 2025-12-31) — Normalized Income: 33575000.00
BMI cash_flow (annual, 2025-12-31) — Operating Cash Flow: 183698000.00
BMI cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 54801000.00
BMI cash_flow (annual, 2025-12-31) — Operating Gains Losses: 136000.00
BMI cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 91000.00
BMI income_statement (annual, 2025-12-31) — Operating Income: 183421000.00
BMI income_statement (quarterly, 2025-12-31) — Operating Income: 43049000.00
BMI income_statement (annual, 2025-12-31) — Operating Revenue: 916663000.00
BMI income_statement (quarterly, 2025-12-31) — Operating Revenue: 220706000.00
BMI balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 29386738.00
BMI balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 29386738.00
BMI balance_sheet (annual, 2025-12-31) — Other Current Assets: 16770000.00
BMI balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 16770000.00
BMI balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 32332000.00
BMI balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 32332000.00
BMI balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 6474000.00
BMI balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 6474000.00
BMI income_statement (annual, 2025-12-31) — Other Income Expense: 112000.00
BMI income_statement (quarterly, 2025-12-31) — Other Income Expense: 28000.00
BMI balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 122196000.00
BMI balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 122196000.00
BMI balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 14953000.00
BMI balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 14953000.00
BMI balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 24162000.00
BMI balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 24162000.00
BMI income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 112000.00
BMI income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 28000.00
BMI balance_sheet (annual, 2025-12-31) — Payables: 72299000.00
BMI balance_sheet (quarterly, 2025-12-31) — Payables: 72299000.00
BMI balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 72299000.00
BMI balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 72299000.00
BMI cash_flow (annual, 2025-12-31) — Pension And Employee Benefit Expense: 136000.00
BMI cash_flow (quarterly, 2025-12-31) — Pension And Employee Benefit Expense: 91000.00
BMI balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 37619000.00
BMI balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 37619000.00
BMI income_statement (annual, 2025-12-31) — Pretax Income: 188657000.00
BMI income_statement (quarterly, 2025-12-31) — Pretax Income: 44642000.00
BMI cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 554000.00
BMI cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 0.00
BMI balance_sheet (annual, 2025-12-31) — Properties: 0.00
BMI balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
BMI cash_flow (annual, 2025-12-31) — Purchase Of Business: -184024000.00
BMI cash_flow (quarterly, 2025-12-31) — Purchase Of Business: 0.00
BMI balance_sheet (annual, 2025-12-31) — Raw Materials: 99604000.00
BMI balance_sheet (quarterly, 2025-12-31) — Raw Materials: 99604000.00
BMI balance_sheet (annual, 2025-12-31) — Receivables: 112356000.00
BMI balance_sheet (quarterly, 2025-12-31) — Receivables: 112356000.00
BMI income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 534593000.00
BMI income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 127719000.00
BMI income_statement (annual, 2025-12-31) — Reconciled Depreciation: 34584000.00
BMI income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 8800000.00
BMI cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -15002000.00
BMI balance_sheet (annual, 2025-12-31) — Retained Earnings: 645876000.00
BMI balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 645876000.00
BMI income_statement (annual, 2025-12-31) — Selling General And Administration: 198649000.00
BMI income_statement (quarterly, 2025-12-31) — Selling General And Administration: 49938000.00
BMI balance_sheet (annual, 2025-12-31) — Share Issued: 37221098.00
BMI balance_sheet (quarterly, 2025-12-31) — Share Issued: 37221098.00
BMI cash_flow (annual, 2025-12-31) — Stock Based Compensation: 9190000.00
BMI cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 2745000.00
BMI balance_sheet (annual, 2025-12-31) — Stockholders Equity: 713294000.00
BMI balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 713294000.00
BMI balance_sheet (annual, 2025-12-31) — Tangible Book Value: 355523000.00
BMI balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 355523000.00
BMI income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
BMI income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
BMI income_statement (annual, 2025-12-31) — Tax Provision: 47023000.00
BMI income_statement (quarterly, 2025-12-31) — Tax Provision: 11067000.00
BMI income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.25
BMI income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.25
BMI balance_sheet (annual, 2025-12-31) — Total Assets: 973577000.00